AI and Cannabis Could Make
Investors Happy
May 23, 2019 -- InvestorsHub NewsWire -- via microcapspeculators.com --
Artificial intelligence (AI) could contribute up to $15.7
trillion to the global economy by 2030 according to PWC,
marijuana sales and ecommerce is just one stop on the path from
seed to sale where artificial intelligence can have a significant
effect. From speeding up processes, reducing errors, and
saving money, artificial intelligence can change the way marijuana
businesses operate and sell.
With sales lagging behind estimates, producers will begin to
look to AI companies to help solve their problems.
That’s why we’re highlighting Gopher Protocol Inc.
(USOTC:
GOPH), an AI/IoT company who has started 2019 off with a
bang. They are the kind of AI play that can help cannabis
producers on several levels. The company
released their AI enabled app based on modern AI
technologies including Deep Neural Network (DNN), vectorization and
other advanced methodologies enabling usage for wide variety of
applications. The company’s Avant! AI system is currently
implementing innovative Machine Learning (ML) methods within the
system that will allow advanced classification and problem
solving. This is big because Avant! will be able to recognize
user's intent, distinguish between different data and analyze
user's sentiment.
The company just released huge news that it has added NLP
(Natural Language Processing), speech recognition support to its
Avant! AI mobile app. That’s the same type of tech that
make’s Amazon’s Alexa and Google Assistant so
popular!
GOPH also announced last week it has filed for international
patent protection (PCT) for its database sharing and management
patent. This unique combination of AI and IoT opportunities
in one stock is the kind of thing big time investors salivate over,
so start your research on GOPH.
Today we are highlighting: Gopher Protocol Inc.
(USOTC:
GOPH), GW Pharmaceuticals plc (NASDAQ:
GWPH), The Green Organic Dutchman (TGODF), Splunk (NASDAQ:
SPLK), Salesforce.com (NYSE:
CRM).
Gopher Protocol Inc. (USOTC:
GOPH) (Market Cap: $28.304M; Share Price:
$0.133) recently released a technology review that
was filed as an exhibit to a Form 8-K with the SEC. - https://www.sec.gov/Archives/edgar/data/1471781/000173112219000209/0001731122-19-000209-index.htm
The Technology Review provides an overview of
GopherInsight™, AVANT! AI, Robotic Research, gNet and
GopherInsight – 5G and walks the reader through developed
and completed systems to potentially upcoming systems from a
technology point of view.
GOPH’s Avant! AI mobile app is synchronized with the Avant! AI
web application (www.avant-ai.net) and is equipped with
personalization and additional features to make it a handy
artificial general intelligence (AGI) agent for the benefit of
users. Avant! AI is an artificial intelligence system that is
capable of processing vast amounts of data efficiently and
quickly. Avant! AI is based on modern AI technologies
including Deep Neural Network (DNN), vectorization and other
advanced methodologies enabling usage for wide variety of
applications. The current release of Avant! AI is targeting
AGI to perform information search and retrieval. The new
mobile application enables question/answer capability for general
topics. Avant! AI searches for online information, sorting
out the best answer and recording it under a personal
account. The system keeps a history of any user's
question/answer data for future use and includes a search mechanism
to retrieve previous topics.
The company’s GopherInsight™ global mesh network technology
platform for both mobile and fixed solutions was tested in
both laboratory and outdoor conditions, and all tests were
successful. "We are glad to announce the completion of our MESH
system, Alpha version. The system has successfully passed all lab
and field testing as scheduled with satisfactory results,"
commented Danny Rittman, Gopher’s Chief Technology Officer. "The
tests covered essential topics that included hardware and software
to ensure high performance and reliable features and
characteristics.”
The company successfully completed testing on their Alpha version
of its global mesh network technology platform GopherInsight™.
The company just signed one of its largest deals to date, an
OEM Licensing Agreement with Shadalane, a leading US-based AKC
kennel who is currently launching its own private-label accessories
and will add Gopher’s wireless mesh networking technology to its
product line.
Also, in April ’19, it announced it has received an International
Search Report and Written Opinion pertaining to its Gopher Radio
Token application from the International Searching Authority under
the Patent Cooperation Treaty. All claims under the Opinion
have been found to be novel and have "inventive step" (i.e., to be
non-obvious). Gopher intends to use its Avant! AI technology
to govern security and vast data processing for the GRT. This
opens an entire world of possibilities that are enabled by a
powerful artificial intelligence system.
________
GW Pharmaceuticals plc (NASDAQ:
GWPH) (Market Cap: $5.75B; Share Price:
$187.21), the world leader in the development and
commercialization of cannabinoid prescription medicines, recently
announced the appointment of Darren Cline as its new U.S. Chief
Commercial Officer. Mr. Cline will lead the Epidiolex®
U.S. commercial organization and is expected to start on April 22,
2019.
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on
discovering, developing, and commercializing cannabinoid
prescription medicines using botanical extracts derived from the
Cannabis plant. Its lead product is Epidiolex, an oral medicine for
the treatment of refractory childhood epilepsies, as well as for
the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous
sclerosis complex, and infantile spasms.
GW commercialized the world's first plant-derived cannabinoid
prescription drug, Sativex® (nabiximols), which is approved for the
treatment of spasticity due to multiple sclerosis in numerous
countries outside the United States and for which the company is
now planning a U.S. Phase 3 trial. The Company has a deep pipeline
of additional cannabinoid product candidates which includes
compounds in Phase 1 and 2 trials for epilepsy, glioblastoma, and
schizophrenia.
________
The Green Organic Dutchman (TGODF) (Market Cap:
$850.426M; Share Price: $3.15) recently participated
in Virtual Investor Conferences.
The Green Organic Dutchman is an Ontario, Canada, based marijuana
company that was IPO’d in spring 2018 and is currently valued at
$957 million.
The Green Organic Dutchman expects that its production capacity
will be 170,000 kg marijuana a year, based on several deals that
have expanded the company’s asset base during 2018.
This includes the June 2018 acquisition of a facility
(approximately 280,000 square foot) that The Green Organic Dutchman
plans to use for producing marijuana-containing edible products and
marijuana-infused beverages. It recently announced that effective
March 25th, 2019 sales of certified-organic cannabis have started
with national distribution to medical patients. The Growers' Circle
is a select group of patients across Canada now receiving TGOD's
first certified-organic flower.
________
Splunk Inc (NASDAQ:
SPLK) (Market Cap: $20.44B; Share Price:
$136.12) recently filed its latest 10-K with
SEC for the fiscal year ended on January 31, 2019. Splunk Inc
provides software products. Its flagship product is Splunk
Enterprise and at its core is a proprietary machine data engine,
comprised of collection, indexing, search, reporting analysis and
data management capabilities.
Recently, it announced that announced that the Orbis Partnership
is using its Splunk® Enterprise and Splunk Enterprise Security (ES)
products to protect itself from cyber-attacks. Orbis, a
partnership which brings together three local councils in Southeast
England, spans across 550 sites and delivers services including
finance, procurement and human resources to over 20,000 users.
Splunk is involved in Artificial Intelligence and the strength
of Splunk’s AI platform lies in its ability to deal with
unstructured data for IT and security. Using machine
learning, the company’s IT Service Intelligence (ITS), a monitoring
and analytics solution that combines big data and AI functionality,
detects, flags and prevents possible anomalies before they impact
revenue and customer experience. ITS also makes predictions
giving organizations visibility across IT and business services and
applications. According to Gartner's ITOM Performance
Analysis: AIOps, ITIM and Other Monitoring Tools, Splunk is ranked
No. 2 with 13.7% market share after IBM. Third-highest market share
is Microsoft with 8.3%.
________
Salesforce.com, Inc. (NYSE:
CRM) (Market Cap $121.540B; Share Price:
$157.64) offered cloud-based solutions for customer
relationship management (CRM) before "the cloud" was part of the
mainstream lexicon or even tech jargon. The company now
sports a $125 billion market cap, achieved in large part by
pioneering the software-as-a-service (SaaS) business model.
And even after gaining all its wisdom from being around so long,
the company still refuses to act its age. Take for instance their
involvement with AI. It currently dominates 20% personalized
Customer Relationship Management software and tools; a dominance
that is the direct result of Salesforce’s platform Einstein AI,
Salesforce Customer 360, and Salesforce Lightning platforms.
According to the company’s published 4Q and FY 2019 (ended January
2019) results, Einstein AI, after using of all the data in
Salesforce—customer data, can deliver more than 6 billion
predictions every day. Last week, it announced that Audi
Germany is pooling its expertise in the area of e-mobility with
Salesforce to deliver smart, personalized customer engagement
throughout the entire customer lifecycle. It also announced new
Einstein services that enable admins and developers to build custom
artificial intelligence — all with just a few clicks or a single
line of code.
Legal Disclaimer:
This article was written by Regal Consulting, LLC (“Regal
Consulting”). Regal Consulting has agreed to a two-month term
consulting agreement with GOPH dated 12/31/18. The agreement
calls for $100,000 in cash per month, and zero shares. Regal
and GOPH have agreed to amend the current agreement, and extend
contract period for six months and increase the stock compensation
to 50,000 restricted 144 shares of GOPH per month. All
payments were made directly by Gopher Protocol, Inc. to Regal
Consulting, LLC. to provide investor relations services, of which
this article is a part of. Regal Consulting also paid one
thousand dollars cash to microcapspeculators.com to distribute this
article. Regal Consulting may have a position in the
securities mentioned in this article at the time of publication,
and may increase or decrease its position without notice. This
article is based on public information and the opinions of Regal
Consulting. GOPH was given an opportunity to edit this
article. This article contains forward-looking statements
that are subject to certain risks and uncertainties that could
cause actual results to differ materially from any results
predicted herein. Regal Consulting is not registered with any
financial or securities regulatory authority, and does not provide
or claim to provide investment advice.
http://www.regalconsultingllc.com/full
legal disclaimer/
Full Legal Disclaimer Click Here.
Contact Information:
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
SOURCE: microcapspeculators.com